Our mission at Quodria is to bring new, effective treatments to patients with chronic skin diseases. Our team of experts are dedicated to developing innovative solutions that address some of the biggest challenges in skin health today.
Quodria brings together a high performing team with a proven track record of working collaboratively in biotech, successfully building companies and taking ideas from laboratory through to successful late-stage clinical testing.
John is an experienced scientist and entrepreneur with over 20 years of experience in both large and small Pharma. John has led drug discovery programs from concept into late-stage clinical development. He founded various biotechnology businesses and has completed multi-million dollar commercial deals.
David has a background in biochemistry, immunology and molecular biology with a PhD from Imperial College London. He has worked in the pharmaceutical industry for more than 20 years and is an experienced leader in drug discovery and development. He has taken products from concept through to late-stage clinical testing.
Mark is a chartered management accountant and experienced finance leader with significant finance and business experience in bioscience, major pharmaceutical and other global R&D-led companies.
Julie is a Senior Principal Scientist with a PhD from Imperial College, London. She has more than 15 years in the pharmaceutical industry in both big Pharma and biotech. At Quodria Julie brings her deep and extensive knowledge in the development of novel topical formulations, as well as the creation and validation of biochemical and immunoassays, cell biology and ex vivo tissue assays.
Sinead is a Senior Analytical Scientist with a strong foundation in bioanalysis and drug product development gained through her work with leading CROs and CDMOs. She provides key analytical support for our projects, leveraging her extensive knowledge of LC-MS/MS and GxP practices to develop and validate the critical assays required for successful formulation development.